Matthew E Korenberg - Net Worth and Insider Trading
Matthew E Korenberg Net Worth
The estimated net worth of Matthew E Korenberg is at least $14 Million dollars as of 2026-08-31. Matthew E Korenberg is the President & COO of Ligand Pharmaceuticals Inc and owns about 50,777 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $14 Million. Details can be seen in Matthew E Korenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew E Korenberg has not made any transactions after 2024-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew E Korenberg
Matthew E Korenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew E Korenberg owns 5 companies in total, including Ligand Pharmaceuticals Inc (LGND) , Ritter Pharmaceuticals Inc (RTTR) , and AIxCrypto Holdings Inc (AIXC) among others .
Click here to see the complete history of Matthew E Korenberg’s form 4 insider trades.
Insider Ownership Summary of Matthew E Korenberg
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-09-23 | VP & Finance and CFO |
| RTTR | Ritter Pharmaceuticals Inc | 2020-06-06 | director |
| AIXC | AIxCrypto Holdings Inc | 2020-05-22 | director |
 | | 2024-12-13 | CFO & Treasurer |
| | 2025-07-15 | director |
Matthew E Korenberg Latest Holdings Summary
Matthew E Korenberg currently owns a total of 1 stock. Matthew E Korenberg owns 50,777 shares of Ligand Pharmaceuticals Inc (LGND) as of September 23, 2024, with a value of $14 Million.
Latest Holdings of Matthew E Korenberg
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-09-23 | 50,777 | 280.64 | 14,250,057 |
Holding Weightings of Matthew E Korenberg
Matthew E Korenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew E Korenberg has made a total of 4 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 16,047 shares on September 23, 2024, which brought Matthew E Korenberg around $2 Million.
Insider Trading History of Matthew E Korenberg
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Matthew E Korenberg Trading Performance
GuruFocus tracks the stock performance after each of Matthew E Korenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew E Korenberg is 27.35%. GuruFocus also compares Matthew E Korenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew E Korenberg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew E Korenberg's insider trading performs compared to the benchmark.
Performance of Matthew E Korenberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.81 | | | | | |
| Relative Return to S&P 500(%) | 16.66 | | | | | |
Matthew E Korenberg Ownership Network
Ownership Network List of Matthew E Korenberg
Ownership Network Relation of Matthew E Korenberg
Matthew E Korenberg Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Matthew E Korenberg is the VP & Finance and CFO of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , CHIEF LEGAL OFFICER & Andrew Reardon , and CEO & President John L Higgins .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Matthew E Korenberg made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 7,638 shares made by John W Kozarich , a net sale of 32,000 shares made by Andrew Reardon , and a net sale of 53,425 shares made by Octavio Espinoza .
In summary, during the past 3 months, insiders sold 71,976 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 71,976 shares. During the past 18 months, 145,843 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 11,010 shares were bought by its insiders, resulting in a net sale of 134,833 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Matthew E Korenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew E Korenberg. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew E Korenberg's mailing address is: La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
